US BIS: Additional EAR Sanctions Against Russia and Belarus — Industrial, Luxury Goods, and Bio-Equipment Expansion (Feb 2023)

Mechanism

This final rule makes four structural expansions to the Russia/Belarus EAR sanctions perimeter under 15 CFR Parts 744 and 746, effective 24 February 2023 (published 27 February 2023, 88 FR 12175–12205, FR Doc 2023-03927, RIN 0694-AJ09):

1. Supplement No. 4 — Industrial sector expansion (+322 HTS-6 items) Three hundred twenty-two new HTS-6 codes were added to the Russian and Belarusian industry-sector sanctions list, covering: drill pipe, casing, tubing, and line pipe; flat-rolled steel and alloy-steel products; pumps, turbines, and filtration/purification machinery; boring and mining equipment; and marine and aviation engines and parts. These items require a BIS licence to export, re-export, or transfer (in-country) to Russia or Belarus, with a policy of denial.

2. Supplement No. 5 — Luxury goods expansion (+276 items) Two hundred seventy-six luxury goods items were added to the luxury-sanctions list targeting Russian and Belarusian oligarchs and malign actors. This expands the consumer-goods layer of the sanctions perimeter beyond the post-24 February 2022 inaugural luxury-goods controls.

3. Supplement No. 6 — Biological and chemical-synthesis equipment The bio-equipment supplement was expanded to add thiafentanil (a synthetic opioid precursor with dual military application), nucleotides, amino acids, peptides, and proteins; microreactors and aerosol-generating equipment; laboratory milling equipment; peptide synthesizers; and enhanced controls on bioreactors and continuous-flow reactors. This targets Russia's emerging biodefence and chemical-synthesis procurement pathway, which prior rounds of controls had not specifically addressed.

4. Supplement No. 2 — HTS-6 code migration The supplement was rewritten to use HTS-6 codes (aligned with EU and G7 partner frameworks) rather than Schedule B codes, facilitating coordinated allied enforcement and reducing transshipment gaps across non-US jurisdictions that use HS rather than Schedule B nomenclature.

5. Supplement No. 3 — Taiwan exclusion Taiwan was added to the list of countries excluded from certain Russian/Belarusian industry-sector licence requirements, in recognition of Taiwan's implementation of substantially equivalent export controls through its own framework.

6. Section 744.7 — In-country transfer extension End-use restrictions under §744.7 were extended to cover in-country transfers inside Russia and Belarus (in addition to export and re-export), closing a loophole where controlled goods already inside Russia could be redistributed to controlled end-users without triggering a BIS licence requirement.

7. Corporate-exit licensing pathway A case-by-case licence-review policy was added for companies curtailing or closing all operations in Russia or Belarus, enabling orderly divestiture of inventory and equipment. A savings clause permitted items already en route on 24 February 2023 to proceed under previous rules through 27 March 2023.

Downstream implications

• The 322-item industrial expansion targeted sectors central to Russia's war-economy supply chain:

oil-and-gas equipment, steel production, and logistics/transport machinery.

• Supplement No. 6 bio/chem controls close a gap identified under the CWC compliance track and

complement concurrent OFAC designations of Russian biodefence-adjacent entities.

• HTS-6 alignment with EU partner frameworks materially improves multilateral enforcement

coordination, reducing the definitional arbitrage Russia exploited via Schedule B vs HTS gaps.

• Taiwan exclusion signalled deepening US–Taiwan technology-partnership alignment, consistent with

the concurrent CHIPS Act industrial-policy context.

• The corporate-exit licensing pathway was operationally significant for multinationals (energy majors,

industrial OEMs) holding Russian inventory at the time of the rule.

Open questions

• Whether Supplement No. 6 bio-equipment controls will be extended to Chinese dual-use purchasers

given overlapping biodefence supply-chain concerns.

• Effectiveness of luxury-goods controls against informal import channels legitimised by Russia's own

March 2022 Resolution 506 parallel-imports regime.